11Aug
Chinese M&A bounces back in Q2 - A surge of interest from inbound investors drives recovery after a sharp fall in Q1
The COVID-19 pandemic hit Chinese M&A hard in Q1, but the second quarter has already witnessed a remarkable recovery with a total of 434 deals announced—an increase of 56% on Q1. Value also rebounded strongly, with deals worth US$58.19 billion recorded during the second quarter, up more than 16% on Q1....
By:
White & Case LLP
Related
The hyper-partisan political warfare in the American health care industry is far from over. But anot...
Read More >
On July 27, 2020, the U.S. Department of Veterans Affairs (VA) issued Circular 26-20-27, dated July ...
Read More >
In Steward Health Care System v. CHSPSC, Judge Sanders found that CHSPSC, an affiliate of Community ...
Read More >
Assembly Bill 51, the controversial law that would have prevented employers from requiring employees...
Read More >
HUD issued a proposed rule to amend its Fair Housing Act design and construction regulations to inco...
Read More >
Seyfarth Synopsis: The U.S. Chemical Safety and Hazard Investigation Board (CSB) has proposed new ac...
Read More >